BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 21324791)

  • 1. An overview of current diagnosis and treatment in ovarian cancer.
    Mould T
    Int J Gynecol Cancer; 2012 May; 22 Suppl 1():S2-4. PubMed ID: 22543914
    [No Abstract]   [Full Text] [Related]  

  • 2. Early-stage ovarian cancer management: still a challenge.
    González Martín A
    Clin Transl Oncol; 2011 Feb; 13(2):67-8. PubMed ID: 21324791
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chemotherapy for ovarian cancer--introduction].
    Yamada H; Sugiyama T
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():540-5. PubMed ID: 15535304
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study by the Working Group in Gynecologic Oncology for therapeutic optimization in advanced FIGO IIb-IV ovarian carcinoma: cisplatin-paclitaxel vs. carboplatin-paclitaxel. AGO Protocol Ovar-3].
    Mettler L
    Zentralbl Gynakol; 1996; 118(6):379-4. PubMed ID: 8768017
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II study.
    Pujade-Lauraine E; Guastalla JP; Weber B; Curé H; Orfeuvre H; Mousseau M; Vincent P; Diéras V; Tubiana-Mathieu N; Jacquin JP; Mignot L; Leduc B; Paraïso D; Viens P
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-30-S15-35. PubMed ID: 9346219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy of intraperitoneal carboplatin and intravenous paclitaxel in suboptimally debulked epithelial ovarian cancer.
    Nagao S; Fujiwara K; Ohishi R; Nakanishi Y; Iwasa N; Shimizu M; Goto T; Shimoya K
    Int J Gynecol Cancer; 2008; 18(6):1210-4. PubMed ID: 18284454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Borderline mucinous tumour with mural nodule of signet ring adenocarcinoma.
    Ong NC; Ostör AG
    Aust N Z J Obstet Gynaecol; 2002 Nov; 42(5):561-2. PubMed ID: 12495115
    [No Abstract]   [Full Text] [Related]  

  • 8. Platinum-based adjuvant chemotherapy on moderate- and high-risk stage I and II epithelian ovarian cancer patients. Long-term single institution experience and literature review.
    García-Sáenz JA; Custodio A; Casado A; Vidart JA; Coronado PJ; Martín M; López-Tarruella S; Puente J; Fernández C; Díaz-Rubio E
    Clin Transl Oncol; 2011 Feb; 13(2):121-32. PubMed ID: 21324801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer statistics, 2010.
    Jemal A; Siegel R; Xu J; Ward E
    CA Cancer J Clin; 2010; 60(5):277-300. PubMed ID: 20610543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial ovarian carcinoma: current evidences and future perspectives in the first-line setting.
    González-Martín A; Toledo G; Chiva L
    Clin Transl Oncol; 2010 Jun; 12(6):418-30. PubMed ID: 20534397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian cancer.
    Hennessy BT; Coleman RL; Markman M
    Lancet; 2009 Oct; 374(9698):1371-82. PubMed ID: 19793610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study.
    Bell J; Brady MF; Young RC; Lage J; Walker JL; Look KY; Rose GS; Spirtos NM;
    Gynecol Oncol; 2006 Sep; 102(3):432-9. PubMed ID: 16860852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma.
    Trimbos JB; Parmar M; Vergote I; Guthrie D; Bolis G; Colombo N; Vermorken JB; Torri V; Mangioni C; Pecorelli S; Lissoni A; Swart AM; ;
    J Natl Cancer Inst; 2003 Jan; 95(2):105-12. PubMed ID: 12529343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma.
    Vergote I; De Brabanter J; Fyles A; Bertelsen K; Einhorn N; Sevelda P; Gore ME; Kaern J; Verrelst H; Sjövall K; Timmerman D; Vandewalle J; Van Gramberen M; Tropé CG
    Lancet; 2001 Jan; 357(9251):176-82. PubMed ID: 11213094
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.